Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
10.1111/j.1463-1326.2011.01505.x Diabetes Obes
Retatrutide (LY-3437943) is an investigational drug developed by Eli Lilly that acts as a triple hormone receptor agonist : GLP-1 (glucagon-like peptide-1) receptor agonist GIP (glucose-dependent insulinotropic polypeptide) receptor agonist Glucagon receptor agonist - read about why this is so important here This triagonist approach amplifies the metabolic impact seen with GLP-1 and GIP combinations like tirzepatide, while also leveraging glucagons thermogenic and energy-expending properties
Discover what this vitamin does for your health and your immunity in our new article
Ozempic, also called semaglutide, may be the most well-known, but five other GLP-1s in an injectable form are used to treat diabetes
Usually, with a level that low, a GP would prescribe 5mg folate daily for three months, then re-test folate levels
